<DOC>
	<DOCNO>NCT01702311</DOCNO>
	<brief_summary>Capillary point-of-care ( POC ) test advocate valuable aid management diabetes hyperglycemia hospital setting . POC test aim collect information BG level different time point day order ass glycemic control guide insulin adjustment/correction dos . Although POC test provide insight day-to-day excursion BG level , bedtime BG test trigger use insulin supplement may result increased frequency hypoglycemia expensive estimate annual cost hospital several hundred million dollar U.S . Accordingly , pilot study aim assess utility POC insulin supplementation ( correction dos ) bedtime improve glycemic control prevent hypoglycemia non-ICU patient type 2 diabetes mellitus ( T2DM ) . A total 250 non-ICU medical surgical patient treat basal bolus regimen undergo POC test meal bedtime ( standard care ) half patient receive insulin correction dos bedtime BG &gt; 140 mg/dL follow slide scale protocol , half follow without insulin supplementation bedtime except extreme hyperglycemia ( BG &gt; 350 mg/dl ) . Patients recruit Emory University Hospital Grady Memorial Hospital .</brief_summary>
	<brief_title>Point-of-Care Glucose Testing Insulin Supplementation</brief_title>
	<detailed_description>The value POC test use insulin supplement ( correction dos ) particular bedtime , prospectively evaluate insulin-treated patient T2DM . In non-ICU setting , practice guideline management hyperglycemia patient T2DM favor use physiologic ( basal-nutritional-correction dose ) insulin regimens slide scale regular insulin . POC test invasive painful , limitation provide glycemic profile incomplete picture BG excursion always accurate method monitor glucose compare laboratory assay addition major expense health care delivery . The overall objective proposal conduct first prospective randomize control trial ( RCT ) determine POC glucose test use insulin supplementation bedtime improve glycemic control prevent hypoglycemia insulin-treated non-ICU patient T2DM . The central hypothesis proposal routine BG measurement insulin supplementation bedtime improve glycemic control reduce frequency hypoglycemia insulin treat medicine surgery patient T2DM .</detailed_description>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<criteria>1 . Male female patient know history T2DM &gt; 3 month 2 . Age 1880 year 3 . Home treatment either diet alone , combination oral antidiabetic agent , noninsulin injectables insulin therapy 4 . BG &gt; 140 mg &lt; 400 mg/dL without laboratory evidence diabetic ketoacidosis 1 . Hyperglycemia without history diabetes 2 . Acute critical illness admit ICU expect require ICU admission 3 . Receiving continuous insulin infusion 4 . Clinically relevant hepatic disease 5 . Patients corticosteroid therapy 6 . Patients creatinine â‰¥ 3.5 mg/dl 7 . Subjects unable sign consent 8 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Point care test</keyword>
	<keyword>Hypoglycemia</keyword>
	<keyword>Basal bolus insulin</keyword>
</DOC>